Ambarella (AMBA) Price Target Raised to $43 at Topeka Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Ambarella (AMBA) PT Raised to $35 at Chardan Capital Markets; 'Neutral' Maintained
September 5, 2014 8:25 AM EDTChardan Capital Markets analyst Jay Srivatsa raised his price target on Ambarella (NASDAQ: AMBA) to $35.00 (from $30.00) following "impressive: Q2 results and guidance but maintained a Neutral rating.
"While we areimpressed with Q2:15 results and Q3:15 guidance, we believe that the companys... More
Ambarella (AMBA) PT Raised to $42 at Ascendiant Capital on Strong Q2
September 5, 2014 8:15 AM EDTAscendiant Capital analysts David Williams and Cody Acree reiterated a Buy rating on Ambarella (NASDAQ: AMBA) and boosted their price target to $42.00 (from $37.00) following strong Q2 results and guidance.
"On a very strong beat and raise, continued strength across all of AMBA's key segments and expanding market... More
Ambarella (AMBA) Tops Q2 EPS by 9c, Sales Beat
September 4, 2014 4:08 PM EDTAmbarella (NASDAQ: AMBA) reported Q2 EPS of $0.37, $0.09 better than the analyst estimate of $0.28. Revenue for the quarter rose 24.6% to $47 million versus the consensus estimate of $44.7 million.
"We are delighted with our second quarter financial results," said Fermi Wang, president and CEO. "We achieved... More
